Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

150.24
BATS BZX Real-Time Price
As of 9:59am ET
 +0.98 / +0.66%
Today’s Change
29.51
Today|||52-Week Range
157.77
+11.72%
Year-to-Date
TESARO Varubi IV Gets Complete Response Letter in the U.S.
Jan 13 / Zacks.com - Paid Partner Content
These 3 Biotech Stocks Are Already Moving Wildly on Thursday
Jan 12 / TheStreet.com - Paid Partner Content
7 Stocks Outperforming the Market
Jan 12 / GuruFocus News - Paid Partner Content
4 Stocks in Focus as Biotech M&A Hopes Surge on Takeda-ARIAD Deal
Jan 10 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close149.26
Today’s open151.11
Day’s range148.65 - 151.20
Volume3,344
Average volume (3 months)1,073,847
Market cap$8.0B
Dividend yield--
Data as of 9:59am ET, 01/19/2017

Growth & Valuation

Earnings growth (last year)-33.19%
Earnings growth (this year)-16.66%
Earnings growth (next 5 years)+24.83%
Revenue growth (last year)--
P/E ratioNM
Price/Sales6,500.72
Price/Book69.21

Competitors

 Today’s
change
Today’s
% change
JAZZJazz Pharmaceuticals...-2.23-1.73%
SGENSeattle Genetics Inc-0.39-0.66%
RDYDr.Reddy's Laborator...-0.75-1.71%
ALKSAlkermes Plc+0.27+0.48%
Data as of 10:01am ET, 01/19/2017

Financials

Next reporting dateFebruary 16, 2017
EPS forecast (this quarter)-$1.95
Annual revenue (last year)$317.0K
Annual profit (last year)-$251.4M
Net profit margin-79,308.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Leon O. Moulder
President, Chief Operating Officer &
Director
Mary Lynne Hedley
Corporate headquarters
Waltham, Massachusetts

Forecasts


Search for Jobs